PHAXIAM Therapeutics
Daniel Cole is currently the VP Corporate Development at ERYTECH Pharma. Previously, Daniel held positions such as Director of Corporate Development at Synta Pharmaceuticals and Spectrum Pharmaceuticals, and Associate Director of Product Marketing at Novacea. Daniel has a strong background in market research, competitive intelligence, and strategic marketing within the biotechnology and pharmaceutical industries. He has a Bachelor of Arts degree in Molecular Cell Biology from the University of California, Berkeley.
This person is not in any offices